Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced Dr. Peter Pardoll, a board certified gastroenterologist, has been elected to Bovie’s board of directors. Dr. Pardoll succeeds Randy Rossi who resigned in March 2009.

Dr. Pardoll has a diverse background in medicine. He is an active member of the National Association of Healthcare Consultants and the founding past managing partner of the Center for Digestive Diseases (CDD) in St. Petersburg, Florida. Dr. Peter Pardoll is the president of Medical Education Associates (MEA), a healthcare consulting group. Dr. Pardoll is a past trustee of the Board of the American College of Gastroenterology and past president of the Florida Gastroenterology Society.

Andrew Makrides, president of Bovie, stated, “I am pleased to welcome Dr. Pardoll to our board. He has long been recognized in the healthcare field witnessed by his inclusion from 1996 to 2005 being honored and elected to “The Best Doctors in America.”

For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie’s website www.boviemedical.com.

This document may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings.

Investor:
Buttonwood Advisory Group, Inc.
John Aneralla, 1-800-940-9087